• Poseida Therapeutics to Present Update on Approach in Allogeneic CAR-T at Society for Immunotherapy of Cancer 34th Annual Meeting

    12 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 5, 2019 /PRNewswire/ - Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced it will present preclin......
    Read more ...

     

  • Oncternal Therapeutics Announces Interim Clinical Data on TK216 in Ewing Sarcoma to Be Presented at the CTOS 2019 Annual Meeting

    12 days ago - By San Diego Biotechnology

    SAN DIEGO--Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that interim data on TK216 - an investigational targeted small m......
    Read more ...